Heart Disease Trial, Recruiting NCT06804499 Sponsor: Tampere Heart Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06804499
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age.
  • People who live in the Wellbeing Services County of Pirkanmaa area and are seeking treatment for coronary artery disease (a condition affecting the arteries that supply blood to the heart).
  • People whose coronary artery disease has been confirmed by a specialist using either a traditional heart artery imaging procedure or a CT scan, assessed according to current medical guidelines.
  • People who have had one of these heart imaging procedures within the last three months.
  • People who have good or moderate ability to carry out everyday activities.

Who may not be able to join:

  • People with a life expectancy of less than one month.
  • People who have previously had treatment for a serious heart valve condition, or for whom such treatment is planned within the next three months.
  • People who already have an implanted heart device called a cardioverter-defibrillator (a device that corrects dangerous heart rhythms), or for whom one is planned within the next three months.
  • People who are currently being treated for an active cancer, including certain blood cancers or spreading solid tumour cancers.
  • People with a significant condition affecting the brain or nervous system, such as dementia, ALS, progressed multiple sclerosis, Parkinson's disease, or a similar condition that affects everyday functioning.
  • People with an intellectual disability or a significant disability that affects thinking and cognitive abilities.
  • People who have a formal "do not resuscitate" decision in place.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tampere Heart Hospital
Registry
ClinicalTrials.gov
Start date
13 January 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Sudden Cardiac Death (SCD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov